Clinical Trial

Efficacy of ActiveMatrix on Spinal SSI Rate

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 7, 2022 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial seeks to provide high level of evidence on the efficacy of ActiveMatrix primarily on spinal surgical site infection rate.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05297513
Lead Sponsor Baylor College of Medicine
Collaborators: Skye Biologics Holdings, LLC
Conditions Spinal Stenosis Lumbar, Surgical Site Infection, Back Pain Lower Back Chronic
Enrollment 275 participants
Start Date 2022-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2022-04-07